Cholesterol and Fatty Acid Synthesis in Islet and Liver Transplant Patients and Effect of Dietary Intervention

Sponsor
University of Alberta (Other)
Overall Status
Completed
CT.gov ID
NCT00947635
Collaborator
Canadian Institutes of Health Research (CIHR) (Other)
46
1
3
43
1.1

Study Details

Study Description

Brief Summary

The purpose is to investigate possible mechanisms of increased blood lipid levels following transplantation, and also to see if a comprehensive dietary intervention is effective in reducing blood lipid levels in post-transplant patients.

Condition or Disease Intervention/Treatment Phase
  • Dietary Supplement: Dietary intervention - supplements
Phase 1/Phase 2

Detailed Description

Post-transplantation patients frequently have an increase in blood lipid levels presumed to be due to immunosuppressive agents, however it is currently unknown the mechanisms by which this occurs. Dietary interventions have frequently been unsuccessful in these patients, which may be due to single-nutrient interventions and lack of support and guidance. This research will use stable isotope methods to estimate cholesterol and fatty acid synthesis to determine if these pathways are affected by immunosuppression in patients before and after islet and liver transplant. In addition, it will be determined if a multi-nutrient dietary intervention will be implemented post-transplant can reduce blood lipid levels in to prevent further polypharmacy these patients.

Study Design

Study Type:
Interventional
Actual Enrollment :
46 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Cholesterol and Fatty Acid Synthesis in Islet and Liver Transplant Patients and Effect of Dietary Intervention
Study Start Date :
Nov 1, 2005
Actual Primary Completion Date :
Jun 1, 2009
Actual Study Completion Date :
Jun 1, 2009

Arms and Interventions

Arm Intervention/Treatment
Experimental: Islet transplant

People with Type 1 diabetes undergoing islet transplantation

Dietary Supplement: Dietary intervention - supplements
Supplement bar & spread formulated with key nutrients (fish oil, phytosterols, almonds, soy protein) shown to help in reducing blood lipid levels

Experimental: Liver transplant

People with liver failure undergoing liver transplantation

Dietary Supplement: Dietary intervention - supplements
Supplement bar & spread formulated with key nutrients (fish oil, phytosterols, almonds, soy protein) shown to help in reducing blood lipid levels

Experimental: Control

Healthy normal people which serve as control group

Dietary Supplement: Dietary intervention - supplements
Supplement bar & spread formulated with key nutrients (fish oil, phytosterols, almonds, soy protein) shown to help in reducing blood lipid levels

Outcome Measures

Primary Outcome Measures

  1. Cholesterol and fatty acid synthesis [Pre-transplant, post-transplant (>3 months after transplant, up to 2 years) and post-dietary intervention (1 month after post-transplant measurement)]

Secondary Outcome Measures

  1. Blood lipid levels [Pre-transplant, post-transplant (>3 months after transplant, up to 2 years) and post-dietary intervention (1 month after post-transplant measurement)]

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • on islet or liver transplant list

  • post-transplant >3 months

  • physically able to participate in study and intervention

Exclusion Criteria:
  • < 18 years of age

  • family history of premature cardiovascular disease or familial hyperlipidemia (control subjects)

  • cholestatic diseases (liver transplant patients)

  • type 2 diabetes

Contacts and Locations

Locations

Site City State Country Postal Code
1 University of Alberta Edmonton Alberta Canada T6G 2P5

Sponsors and Collaborators

  • University of Alberta
  • Canadian Institutes of Health Research (CIHR)

Investigators

  • Principal Investigator: Michael T Clandinin, PhD, University of Alberta

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
, ,
ClinicalTrials.gov Identifier:
NCT00947635
Other Study ID Numbers:
  • Islet-Liver-MTC
First Posted:
Jul 28, 2009
Last Update Posted:
Jul 28, 2009
Last Verified:
Jul 1, 2009

Study Results

No Results Posted as of Jul 28, 2009